CLOs on the Move

SteadyMed

www.steadymed.com

 
SteadyMed Therapeutics, Inc. is a Specialty Pharmaceutical Company. SteadyMed leverages its PatchPump platform to develop its own therapeutic portfolio and partners to optimize the delivery of high volume (greater than two mL), high value, small molecule or biologic drugs. Our family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner. SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications: Extending the limits of parenteral therapeutics to restore freedom, joy and dignity to patients’ lives.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.steadymed.com
  • 2603 Camino Ramon Suite 350
    San Ramon, CA USA 94583
  • Phone: 925.272.4999

Executives

Name Title Contact Details

Similar Companies

RIEMSER

RIEMSER is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sonendo

Sonendo, Inc. is a privately held, venture-backed company developing innovative technologies to transform endodontic therapy. Sonendo`s Multisonic Ultracleaning technology addresses the challenges that currently exist in endodontic treatment, offering a solution to the problems that exist within traditional root canal therapy.

Elucid

Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe

Riverain Technologies

Riverain Technologies is dedicated to thoracic imaging, providing software tools to aid clinicians in the efficient, effective early detection of lung disease. With Riverain`s ClearRead applications, clinicians are empowered by tools that enable them to read faster and more effectively across the entire enterprise.

Guerbet

Guerbet is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.